Extended mathematical model for "in vivo" quantification of the interaction betweeen atazanavir and bilirubin.

about

Extended mathematical model for "in vivo" quantification of the interaction betweeen atazanavir and bilirubin.

Item

http://www.wikidata.org/entity/Q43699242

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@en

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@nl

type

Item

label

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@en

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@nl

prefLabel

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@en

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@nl

P1476

Extended mathematical model fo ...... eeen atazanavir and bilirubin.

@en

P2093

Alberto-Fermín Apesteguia

http://www.w3.org/2001/XMLSchema#string

Nieves Domeque

http://www.w3.org/2001/XMLSchema#string

Roberto Lozano

http://www.w3.org/2001/XMLSchema#string

P2860

The original Michaelis constant: translation of the 1913 Michaelis-Menten paper

Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6

Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection

A review and assessment of potential sources of ethnic differences in drug responsiveness.

P304

161-167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.234

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24243081

http://www.w3.org/2001/XMLSchema#string